Results 191 to 200 of about 32,827 (233)

[Tumor-secreted dentin sialophosphoprotein induces oxaliplatin resistance in colorectal cancer through an integrin αvβ3-dependent pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Liu C, Ning Z, Wu J, Liu W, Lin C, Xu J, Zhou R, Zhao L.   +7 more
europepmc   +1 more source

Correction: PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathway. [PDF]

Front Cell Dev Biol
Li H, Wang C, Lan L, Wu W, Evans I, Ruiz EJ, Yan L, Zhou Z, Oliveira JM, Reis RL, Hu Z, Chen W, Behrens A, He Y, Zhang C.   +14 more
europepmc   +1 more source

Targeting the <i>ZMYM2-ANXA9</i> Axis with <i>FLT3</i> Inhibitor G749 Overcomes Oxaliplatin Resistance in Colorectal Cancer. [PDF]

Biomedicines
Lin D, Xu Y, Zhan H, Liang Y, Liu R, Liu J, Luo D, Chen X, Cai J, Zou Y.   +9 more
europepmc   +1 more source

Mechanical forces inducing oxaliplatin resistance in pancreatic cancer can be targeted by autophagy inhibition. [PDF]

Commun Biol
Kalli M, Mpekris F, Charalambous A, Michael C, Stylianou C, Voutouri C, Hadjigeorgiou AG, Papoui A, Martin JD, Stylianopoulos T.   +9 more
europepmc   +1 more source

CRCs-CAFs crosstalk-targeted nano-delivery system reprograms tumor microenvironment for oxaliplatin resistance reversing and liver metastasis inhibition in colorectal cancer. [PDF]

Bioact Mater
Liu H, Xu C, Wang P, Guo L, Yan X, Zhou R, Tang Y, Wang S, Chen J, Wang Q, Tian H.   +10 more
europepmc   +1 more source

ALYREF-Mediated Regulation of TBL1XR1 and KMT2E Synergistically Upregulates APOC1, Contributing to Oxaliplatin Resistance in Esophageal Cancer. [PDF]

Cancer Res Treat
Hu J, Liu Q, Feng B, Lu Y, Chen K.
europepmc   +1 more source

The expression of exosomal and cellular miRNAs in predicting oxaliplatin resistance in colorectal cancer cells: an in silico and in vitro study. [PDF]

BMC Cancer
Deli H, Vakili-Ghartavol Z, Asgari Y, Tavoosidana G, Eftekhar E, Ghahremani MH.   +5 more
europepmc   +1 more source

Correction: TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach. [PDF]

PLoS One
Cheraghi-Shavi T, Jalal R, Minuchehr Z, Mahjoubi F.   +3 more
europepmc   +1 more source

Oxygen vacancy-engineered bimetallic nanozymes for disrupting electron transport chain and synergistic multi-enzyme activity to reverse oxaliplatin resistance in colorectal cancer. [PDF]

J Nanobiotechnology
Zhong D, Yang X, Yang J, Luo Z, Feng Z, Ma M, Liao Y, Tang Y, Wen Y, Liu J, Hu S.   +10 more
europepmc   +1 more source

Ferroptosis-related oxaliplatin resistance in multiple cancers: Potential roles and therapeutic Implications. [PDF]

Heliyon
Zhong S, Wang Z, Yang J, Jiang D, Wang K.   +4 more
europepmc   +1 more source